Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial – The Lancet Respiratory Medicine Commentaries: Safety and efficacy of tixagevimab–cilgavimab in preventing severe COVID – News Medical Expert reaction to results of the TACKLE Phase 3 trial of Evusheld (tixagevimab and cilgavimab) […]

The post RCT: Intramuscular tixagevimab–cilgavimab may benefit non-hospitalized unvaccinated adults with Covid-19. appeared first on Links Medicus.